Sterling Pharma Solutions Inaugurates its New Material Science Center

Pharma Tech Outlook: Pharma Tech Magazine

Sterling Pharma Solutions Inaugurates its New Material Science Center

By Pharma Tech Outlook | Monday, October 19, 2020

Sterling Pharma Solutions has opened a new material science center.

FREMONT, CA: A global contract development and manufacturing organization (CDMO), Sterling Pharma Solutions, has opened its £11 million material science center (MSC). This new multi-million pound MSC is of three floors, and it also comprises six ISO Class 8 cleanrooms, which serve as a suite for operations such as milling and micronization. The facility also supports warehousing and workshopping units to take care of milling. And a novel and fully equipped state and analytics lab is also a part of the new inauguration.

The new MSC is said to offer a wide array of expert and specialist solid-state chemistry and dynamic assistance in carrying out milling operations in order to complement the services that are already being delivered to the users. Specifically envisioning helping those set of customers who are looking to access the company’s solid form services, the MSC is equipped with purposeful algorithms that have the capability to sustainably manage the facility and take care of operations such as product processing. The center aims to increase facility efficiency by reducing risks, tackling challenges, and offering highly cost-effective solutions and services.  

 Sterling Pharma Solutions is a market leader and well-established developer and manufacturer of pharmaceutical APIs. Having sites in the U.K. and the U.S., this pharma player has specialized in hazardous chemistry and handling controlled substances. Sterling Pharma Solutions is devoted to continuously catering to the needs of its clients and customers by coming up with futuristic and innovative solutions. The company aims at tackling customer challenges such as the process of handling potent molecules and the skill of enhancing operational efficiency and effectiveness. 

See Also : Life science Review

Weekly Brief

Read Also